For patients in rural areas who may not have access to MRI services, the U.S. Food and Drug Administration (FDA) has opened the door for one to come to you.

The American Cancer Society (ACS) has updated its guidelines for lung cancer screening, recommending that nearly 5 million more Americans undergo CT scans. This marks the first change to the screening recommendations in a decade.

GE Healthcare has received clearance from the U.S. Food and Drug Administration (FDA) for its latest image-guided system (IGS) for interventional cardiology, Allia IGS Pulse. Allia IGS Pulse runs on the company’s Allia Platform and was designed with interventional cardiologists in mind. The angiography system includes a monopolar X-ray tube for acquiring the cardiac images...

A group of Dutch researchers from the University of Amsterdam may have devised a method to predict foetal birth weight using ultrasound scans.

A new survey reveals less than half of adults recognise common breast cancer symptoms. Further, most women don’t fear getting the disease.

The U.S. Food and Drug Administration (FDA) has granted Paige, a technology company that supports cancer diagnosis, Breakthrough Device Designation for its artificial intelligence application, Paige Lymph Node. The Breakthrough Device Designation is awarded to technologies with the potential to improve diagnosis or treatment of life-threatening diseases.

Swiss pharmaceutical company Roche is teaming up with artificial intelligence vendor Ibex Medical Analytics and Amazon Web Services (AWS), the cloud hosting arm of Amazon, to bring AI-driven diagnostic support tools to pathology laboratories. Roche, Ibex and AWS have collaborated to enable access to Ibex’s AI-powered decision support tools through Roche’s Navify digital pathology platform.

Medical imaging company Annalise.ai announced the introduction of a new AI triage tool that automatically analyzes radiology reports and prioritizes their review based on the potential for containing critical findings.

Insight Medbotics has gained clearance from the U.S. Food and Drug Administration (FDA) for IGAR, a new robotics system designed to operate within the confines of an MRI bore.

The U.S. Food and Drug Administration has cleared a new artificial intelligence tool aimed at boosting the quality of prenatal ultrasound exams.